These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 1607000)

  • 41. Influence of renal failure, rheumatoid arthritis and old age on the pharmacokinetics of diflunisal.
    Erikson LO; Wåhlin-Boll E; Odar-Cederlöf I; Lindholm L; Melander A
    Eur J Clin Pharmacol; 1989; 36(2):165-74. PubMed ID: 2721541
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacokinetics of aztreonam in patients with chronic renal failure.
    Fillastre JP; Leroy A; Baudoin C; Humbert G; Swabb EA; Vertucci C; Godin M
    Clin Pharmacokinet; 1985; 10(1):91-100. PubMed ID: 4038635
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Meropenem pharmacokinetics in children and adolescents receiving hemodialysis.
    Goldstein SL; Murry DJ; May S; Aleksic A; Sowinski KM; Blaney S
    Pediatr Nephrol; 2001 Dec; 16(12):1015-8. PubMed ID: 11793091
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A comparison of the pharmacokinetics of meropenem after intravenous administration by injection over 2, 3 and 5 minutes.
    Jones HK; Kelly HC; Hutchison M; Yates RA; Ross F; Lomax C; Freestone S; Webb D
    Eur J Drug Metab Pharmacokinet; 1997; 22(3):193-9. PubMed ID: 9358198
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The concentration-dependent disposition of intravenous p-aminohippurate in subjects with normal and impaired renal function.
    Prescott LF; Freestone S; McAuslane JA
    Br J Clin Pharmacol; 1993 Jan; 35(1):20-9. PubMed ID: 8448064
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Metabolic clearance rate of biosynthetic growth hormone after endogenous growth hormone suppression with a somatostatin analogue in chronic renal failure patients and control subjects.
    García-Mayor RV; Pérez AJ; Gandara A; Andrade A; Mallo F; Casanueva FF
    Clin Endocrinol (Oxf); 1993 Sep; 39(3):337-43. PubMed ID: 8222296
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Meropenem pharmacokinetics and penetration into an inflammatory exudate.
    Wise R; Logan M; Cooper M; Ashby JP; Andrews JM
    Antimicrob Agents Chemother; 1990 Aug; 34(8):1515-7. PubMed ID: 2221860
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacokinetics and safety of a new parenteral carbapenem antibiotic, biapenem (L-627), in elderly subjects.
    Kozawa O; Uematsu T; Matsuno H; Niwa M; Takiguchi Y; Matsumoto S; Minamoto M; Niida Y; Yokokawa M; Nagashima S; Kanamaru M
    Antimicrob Agents Chemother; 1998 Jun; 42(6):1433-6. PubMed ID: 9624490
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Single-dose pharmacokinetics of recombinant human erythropoietin in patients with various degrees of renal failure.
    Kindler J; Eckardt KU; Ehmer B; Jandeleit K; Kurtz A; Schreiber A; Scigalla P; Sieberth HG
    Nephrol Dial Transplant; 1989; 4(5):345-9. PubMed ID: 2505184
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacokinetics of ornidazole in patients with renal insufficiency; influence of haemodialysis and peritoneal dialysis.
    Merdjan H; Baumelou A; Diquet B; Chick O; Singlas E
    Br J Clin Pharmacol; 1985 Feb; 19(2):211-7. PubMed ID: 3986079
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Pharmacokinetics of habekacin in patients with chronic renal insufficiency].
    Fillastre JP; Leroy A; Humbert G; Moulin B; Bernadet P; Josse S
    Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):739-41. PubMed ID: 3309806
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacokinetics of nomifensine in impaired renal function.
    Ringoir S; Lameire N; Munche M; Heptner W; Taeuber K
    Br J Clin Pharmacol; 1977; 4Suppl 2(Suppl 2):129S-134S. PubMed ID: 334214
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Differential effect of chronic renal failure on the pharmacokinetics of lidocaine in patients receiving and not receiving hemodialysis.
    De Martin S; Orlando R; Bertoli M; Pegoraro P; Palatini P
    Clin Pharmacol Ther; 2006 Dec; 80(6):597-606. PubMed ID: 17178261
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Plasma pharmacokinetics and tissue fluid concentrations of meropenem after intravenous and subcutaneous administration in dogs.
    Bidgood T; Papich MG
    Am J Vet Res; 2002 Dec; 63(12):1622-8. PubMed ID: 12492274
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacokinetics of oral talinolol following a single dose and during steady state in patients with chronic renal failure and healthy volunteers.
    Krueger M; Achenbach H; Terhaag B; Haase H; Richter K; Oertel R; Preiss R
    Int J Clin Pharmacol Ther; 2001 Feb; 39(2):61-6. PubMed ID: 11270803
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacokinetics of azlocillin in subjects with normal and impaired renal function.
    Leroy A; Humbert G; Godin M; Fillastre JP
    Antimicrob Agents Chemother; 1980 Mar; 17(3):344-9. PubMed ID: 7425600
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Elimination of meropenem during continuous veno-venous haemofiltration and haemodiafiltration in patients with acute renal failure.
    Valtonen M; Tiula E; Backman JT; Neuvonen PJ
    J Antimicrob Chemother; 2000 May; 45(5):701-4. PubMed ID: 10797097
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacokinetics of glycopyrronium in uraemic patients.
    Kirvelä M; Ali-Melkkilä T; Kaila T; Iisalo E; Lindgren L
    Br J Anaesth; 1993 Sep; 71(3):437-9. PubMed ID: 8398530
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cefmenoxime pharmacokinetics in healthy volunteers and subjects with renal insufficiency and on hemodialysis.
    Gambertoglio JG; Alexander DP; Barriere SL
    Antimicrob Agents Chemother; 1984 Dec; 26(6):845-9. PubMed ID: 6098220
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacokinetics of cefoperazone (2.0 g) and sulbactam (1.0 g) coadministered to subjects with normal renal function, patients with decreased renal function, and patients with end-stage renal disease on hemodialysis.
    Reitberg DP; Marble DA; Schultz RW; Whall TJ; Schentag JJ
    Antimicrob Agents Chemother; 1988 Apr; 32(4):503-9. PubMed ID: 3377461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.